|
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
relating to certain practices of health benefit plan issuers to |
|
encourage the use of certain physicians and health care providers |
|
and rank physicians. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. Subchapter I, Chapter 843, Insurance Code, is |
|
amended by adding Section 843.322 to read as follows: |
|
Sec. 843.322. INCENTIVES TO USE CERTAIN PHYSICIANS OR |
|
PROVIDERS. (a) A health maintenance organization may provide |
|
incentives for enrollees to use certain physicians or providers |
|
through modified deductibles, copayments, coinsurance, or other |
|
cost-sharing provisions. |
|
(b) A health maintenance organization that encourages an |
|
enrollee to obtain a health care service from a particular |
|
physician or provider, including offering incentives to encourage |
|
enrollees to use specific physicians or providers, or that |
|
introduces or modifies a tiered network plan or assigns physicians |
|
or providers into tiers, has a fiduciary duty to the enrollee or |
|
group contract holder to engage in that conduct only for the primary |
|
benefit of the enrollee or group contract holder. |
|
SECTION 2. Section 1301.0045(a), Insurance Code, is amended |
|
to read as follows: |
|
(a) Except as provided by Sections [Section] 1301.0046 and |
|
1301.0047, this chapter may not be construed to limit the level of |
|
reimbursement or the level of coverage, including deductibles, |
|
copayments, coinsurance, or other cost-sharing provisions, that |
|
are applicable to preferred providers or, for plans other than |
|
exclusive provider benefit plans, nonpreferred providers. |
|
SECTION 3. Subchapter A, Chapter 1301, Insurance Code, is |
|
amended by adding Section 1301.0047 to read as follows: |
|
Sec. 1301.0047. INCENTIVES TO USE CERTAIN PHYSICIANS OR |
|
HEALTH CARE PROVIDERS. (a) An insurer may provide incentives for |
|
insureds to use certain physicians or health care providers through |
|
modified deductibles, copayments, coinsurance, or other |
|
cost-sharing provisions. |
|
(b) An insurer that encourages an insured to obtain a health |
|
care service from a particular physician or health care provider, |
|
including offering incentives to encourage insureds to use specific |
|
physicians or providers, or that introduces or modifies a tiered |
|
network plan or assigns physicians or providers into tiers, has a |
|
fiduciary duty to the insured or policyholder to engage in that |
|
conduct only for the primary benefit of the insured or |
|
policyholder. |
|
SECTION 4. Section 1460.003, Insurance Code, is amended by |
|
amending Subsection (a) and adding Subsection (a-1) to read as |
|
follows: |
|
(a) A health benefit plan issuer, including a subsidiary or |
|
affiliate, may not rank physicians or[,] classify physicians into |
|
tiers based on performance[, or publish physician-specific |
|
information that includes rankings, tiers, ratings, or other |
|
comparisons of a physician's performance against standards, |
|
measures, or other physicians,] unless: |
|
(1) the standards used by the health benefit plan |
|
issuer to rank or classify are propagated or developed by an |
|
organization designated by the commissioner through rules adopted |
|
under Section 1460.005; |
|
(2) the ranking, comparison, or evaluation: |
|
(A) is disclosed to each affected physician at |
|
least 45 days before the date the ranking, comparison, or |
|
evaluation is released, published, or distributed to enrollees by |
|
the health benefit plan issuer; and |
|
(B) identifies which products or networks |
|
offered by the health benefit plan issuer the ranking, comparison, |
|
or evaluation will be used for; and |
|
(3) each affected physician is given an easy-to-use |
|
process to identify discrepancies between the standards and the |
|
ranking, comparison, or evaluation as propagated by the health |
|
benefit plan issuer [the standards used by the health benefit plan |
|
issuer conform to nationally recognized standards and guidelines as |
|
required by rules adopted under Section 1460.005; |
|
[(2) the standards and measurements to be used by the |
|
health benefit plan issuer are disclosed to each affected physician |
|
before any evaluation period used by the health benefit plan |
|
issuer; and |
|
[(3) each affected physician is afforded, before any |
|
publication or other public dissemination, an opportunity to |
|
dispute the ranking or classification through a process that, at a |
|
minimum, includes due process protections that conform to the |
|
following protections: |
|
[(A) the health benefit plan issuer provides at |
|
least 45 days' written notice to the physician of the proposed |
|
rating, ranking, tiering, or comparison, including the |
|
methodologies, data, and all other information utilized by the |
|
health benefit plan issuer in its rating, tiering, ranking, or |
|
comparison decision; |
|
[(B) in addition to any written fair |
|
reconsideration process, the health benefit plan issuer, upon a |
|
request for review that is made within 30 days of receiving the |
|
notice under Paragraph (A), provides a fair reconsideration |
|
proceeding, at the physician's option: |
|
[(i) by teleconference, at an agreed upon |
|
time; or |
|
[(ii) in person, at an agreed upon time or |
|
between the hours of 8:00 a.m. and 5:00 p.m. Monday through Friday; |
|
[(C) the physician has the right to provide |
|
information at a requested fair reconsideration proceeding for |
|
determination by a decision-maker, have a representative |
|
participate in the fair reconsideration proceeding, and submit a |
|
written statement at the conclusion of the fair reconsideration |
|
proceeding; and |
|
[(D) the health benefit plan issuer provides a |
|
written communication of the outcome of a fair reconsideration |
|
proceeding prior to any publication or dissemination of the rating, |
|
ranking, tiering, or comparison. The written communication must |
|
include the specific reasons for the final decision]. |
|
(a-1) If a physician submits information to a health benefit |
|
plan issuer under Subsection (a)(3) sufficient to establish a |
|
discrepancy, the health benefit plan issuer must remedy the |
|
discrepancy by the later of: |
|
(1) publication; or |
|
(2) the 30th day after the date the health benefit plan |
|
issuer receives the information. |
|
SECTION 5. Section 1460.005(c), Insurance Code, is amended |
|
to read as follows: |
|
(c) In adopting rules under this section, the commissioner |
|
may only designate [shall consider the standards, guidelines, and |
|
measures prescribed by nationally recognized] organizations that |
|
meet the following requirements: |
|
(1) the prescribing organization is bona fide and |
|
unbiased toward or against any medical provider; |
|
(2) the standards to be used in rankings, comparisons, |
|
or evaluations: |
|
(A) are nationally recognized, or based on |
|
expert-provider consensus or leading clinical evidence-based |
|
scholarship; |
|
(B) have a publicly transparent methodology; and |
|
(C) if based on clinical outcomes, are |
|
risk-adjusted; and |
|
(3) the prescribing organization has an easy-to-use |
|
process by which a medical provider may report data, evidentiary, |
|
factual, or mathematical errors for prompt investigation and, if |
|
appropriate, correction [establish or promote guidelines and |
|
performance measures emphasizing quality of health care, including |
|
the National Quality Forum and the AQA Alliance. If neither the |
|
National Quality Forum nor the AQA Alliance has established |
|
standards or guidelines regarding an issue, the commissioner shall |
|
consider the standards, guidelines, and measures prescribed by the |
|
National Committee on Quality Assurance and other similar national |
|
organizations. If neither the National Quality Forum, nor the AQA |
|
Alliance, nor other national organizations have established |
|
standards or guidelines regarding an issue, the commissioner shall |
|
consider standards, guidelines, and measures based on other bona |
|
fide nationally recognized guidelines, expert-based physician |
|
consensus quality standards, or leading objective clinical |
|
evidence and scholarship]. |
|
SECTION 6. This Act takes effect September 1, 2025. |